×
Overview
DIA Korea Annual Meeting 2026 will convene global regulators, industry, and academic experts to discuss how regulatory frameworks can be effectively translated into real-world clinical development. Under the theme “From Regulation to Reality,” the program will feature key regulatory perspectives from leading authorities and address core topics such as clinical trial operations, digital innovation, real-world evidence, and patient centricity.
The second day will include a joint conference co-organized by MFDS, DIA, and KRSC, focusing on regulatory science and collaborative approaches to strengthening Korea’s clinical development ecosystem.
Program Committee
-
Yil-Seob Lee, MD, PhD Professor
CHA Bundang Medical Center , Korea, Republic of -
Youngju Choi, PhD Director General of Biopharmaceutical & Herbal Medicine Evaluation Department
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of -
Juhye Kang, PhD Director General
MFDS, NIFDS, Korea, Republic of -
In-sook Park, PhD Director General
Korean Regulatory Science Center, Korea, Republic of -
Young Joo Park, PhD, MPH VP, Korea, Singapore, and Southeast Asia
DIA, Korea, Republic of -
Hye Ryun Esther Bahng, MSc Senior Director of Market Access and Regulatory Affairs
Market Access & Regulatory Affairs, Astrazeneca, Korea, Republic of -
Yunni Lim, RPh Clinical Operations Portfolio Leader / President, KCDA
Roche Korea Co Ltd, Korea, Republic of -
Kyung-Sang Yu, MD, PhD, MBA Professor, Department of Clinical Pharmacology,
Seoul National University , Korea, Republic of -
Joon-woo Bahn, MD, PhD Professor
Asan Medical Center, Department of Convergence Medicine,, Korea, Republic of -
Hyungjin Jung, MD, MBA Senior Director
Johnson & Johnson Korea (J & J KR), Korea, Republic of -
Hye Jong Yoo, RPh Executive Director
AstraZeneca , Korea, Republic of -
Ju-Young Shin, PharmD, PhD Professor
School of Pharmacy, Sungkyunkwan University, Korea, Republic of -
Min-Jung Lim, MPharm, RPh CEO & Senior Pharmacovigilance Consultant
MediSafe, Pharmacovigilance Services, Korea, Republic of -
Sora Lee, MBA, MPharm, RPh Vice President, General Manager Korea
Syneos Health Inc., Korea, Republic of -
Amy (Hyunjoo) Lee, MBA, RPh Executive Director, Global Clinical Trial Operation
MSD Korea Ltd., Korea, Republic of -
Deborah Chee, MD, PhD, MBA Partner
Gateway Sciences , Korea, Republic of
Have an account?